Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
|
CN |
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
KR |
|
Wir Asia Tbk PT
IDX:WIRG
|
ID |
|
America Movil SAB de CV
NYSE:AMX
|
MX |
|
Noah Holdings Ltd
NYSE:NOAH
|
CN |
|
Monex Group Inc
TSE:8698
|
JP |
|
Charlotte's Web Holdings Inc
TSX:CWEB
|
US |
|
Made Tech Group PLC
LSE:MTEC
|
UK |
|
Turkiye Sise ve Cam Fabrikalari AS
IST:SISE.E
|
TR |
|
3M Co
NYSE:MMM
|
US |
|
Minerva SA
BOVESPA:BEEF3
|
BR |
|
DXC Technology Co
NYSE:DXC
|
US |
|
Vytrus Biotech SA
MAD:VYT
|
ES |
Profitability Summary
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Margins Comparison
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Competitors
| Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|---|
| CN |
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
31.7B CNY |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
31.7B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
